Summary of results: Pain‐free and headache relief | |||||||
Baseline pain | Studies |
Attacks treated |
Treatment (%) |
Placebo or comparator (%) |
Relative benefit (95% CI) |
NNT (95% CI) |
|
Pain‐free at 2 h | |||||||
Naproxen 500/825 mg vs placebo | ≥ mod | 4 | 2149 | 17 | 8 | 2.0 (1.6 to 2.6) | 11 (8.7 to 17) |
Naproxen 500 mg vs placebo | ≥ mod | 3 | 1951 | 16 | 9 | 1.9 (1.5 to 2.4) | 13 (9.7 to 22) |
Naproxen 500 mg vs sumatriptan 50 mg | ≥ mod | 1 | 474 | 18 | 20 | Not calculated | Not calculated |
Headache relief at 2 h | |||||||
Naproxen 500/825 mg vs placebo | ≥ mod | 4 | 2149 | 45 | 29 | 1.6 (1.4 to 1.8) | 6.0 (4.8 to 7.9) |
Naproxen 500 mg vs placebo | ≥ mod | 3 | 1951 | 44 | 28 | 1.6 (1.4 to 1.8) | 6.2 (4.9 to 8.3) |
Naproxen 500 mg vs sumatriptan 50 mg | ≥ mod | 1 | 474 | 46 | 49 | Not calculated | Not calculated |
Sustained pain‐free during the 24 h post dose | |||||||
Naproxen 500/825 mg vs placebo | ≥ mod | 4 | 2149 | 12 | 7 | 1.8 (1.4 to 2.4) | 19 (13 to 34) |
Naproxen 500 mg vs placebo | ≥ mod | 3 | 1951 | 11 | 7 | 1.6 (1.2 to 2.1) | 26 (16 to 70) |
Naproxen 500 mg vs sumatriptan 50 mg | ≥ mod | 1 | 474 | 12 | 11 | Not calculated | Not calculated |
Sustained headache relief during the 24 h post dose | |||||||
Naproxen 500/825 mg vs placebo | ≥ mod | 4 | 2149 | 30 | 18 | 1.7 (1.5 to 2.0) | 8.3 (6.4 to 12) |
Naproxen 500 mg vs placebo | ≥ mod | 3 | 1951 | 28 | 17 | 1.7 (1.4 to 2.0) | 9.3 (6.9 to 14) |
Naproxen 500 mg vs sumatriptan 50 mg | ≥ mod | 1 | 474 | 25 | 29 | Not calculated | Not calculated |